How to Handle Unexpected Failure During Site Transfer


Published on 04/06/2026

Addressing Unexpected Challenges During a Site Transfer in Pharma

In the highly regulated pharmaceutical environment, site-to-site transfers are frequently challenged by unexpected failures that can jeopardize compliance, product quality, and operational timelines. This article recounts a real-world scenario where a pharmaceutical company encountered significant issues during a facility transfer and details how they effectively managed the situation. Readers will gain insight into practical problem-solving strategies, resulting in actionable steps applicable in their own operations.

By detailing the identification of symptoms, containment, investigation processes, corrective and preventive actions, and lessons learned, this article aims to equip pharma professionals with a structured approach to manage site transfer risks effectively.

Symptoms/Signals on the Floor or in the Lab

During a recent site transfer of an injectable product, initial symptoms began to surface during stability testing at the receiving site. The following signals indicated a potential issue:

  • Unexpected Failures in Stability Samples: The stability samples from the first batch exhibited higher-than-normative degradation levels.
  • Out-of-Specification (OOS) Reports: Several OOS results were recorded on potency and particulate matter during analysis.
  • Equipment Performance
Issues: New equipment installed at the receiving site failed to calibrate properly, leading to inconsistent results.
  • Staff Inexperience: Operators at the new site reported uncertainty about required procedures, leading to potential deviations.
  • These factors raised immediate red flags regarding the site readiness and the facility fit assessment prior to the transfer.

    Likely Causes

    Determining the root causes of such failures is crucial for effective resolution. Causes can typically be categorized using the “5M” approach: Materials, Method, Machine, Man, and Measurement.

    Cause Category Potential Causes
    Materials Incompatibility of raw materials sourced from different suppliers; degradation due to improper storage conditions.
    Method Variations in standard operating procedures (SOPs) not updated post-transfer; lack of clarity in analytical methods used.
    Machine Calibration errors and improper equipment installation at the receiving site.
    Man Operator inexperience with new equipment; inadequate training on protocols.
    Measurement Unexpected variability in assay results due to lack of method validation across sites.

    Immediate Containment Actions (First 60 Minutes)

    In the first hour upon detection of these failures, several containment actions were implemented to minimize risk:

    1. Immediate Quarantine: All batches produced and all incoming materials were quarantined to prevent further processing.
    2. Team Briefing: The Quality Assurance (QA) and Manufacturing teams were convened to assess the current situation and determine necessary steps.
    3. Initial Assessment: A preliminary assessment of the OOS results was conducted to understand the extent of deviation from standards.
    4. Alerting Regulatory Affairs: The Regulatory Affairs team was informed in order to prepare for any necessary reporting to agencies.
    5. Documentation: All relevant logs and batch records were secured as evidence for subsequent investigation.

    Investigation Workflow

    Following the containment measures, an in-depth investigation was initiated. The investigation workflow included the following steps:

    1. Data Collection: Detailed retrieval of batch production records, stability test results, equipment calibration logs, and training records of operators.
    2. Root Cause Hypothesis Development: Formulation of hypotheses based on collected data for further validation.
    3. Analysis of Trends: Application of statistical techniques to analyze trends in the data collected, including variability from expected results.
    4. Cross-function Team Collaboration: Engaging cross-functional teams including Quality Control (QC), Engineering, and Production to obtain different perspectives on the issue.

    Root Cause Tools (5-Why, Fishbone, Fault Tree) and When to Use Which

    You can utilize various root cause analysis tools to determine underlying problems. Below is a brief overview of three effective techniques:

    • 5-Why Analysis: This method is effective when a straightforward problem arises. By repeatedly asking “Why?” you can peel back layers to uncover the root cause.
    • Fishbone Diagram: Also known as Ishikawa’s diagram, it helps to categorize potential causes into major areas (e.g., machine, methods) and visualize relationships.
    • Fault Tree Analysis (FTA): Use FTA for complex problems where multiple causes may interact. It provides a structured methodology for decomposing events into their causes.

    CAPA Strategy (Correction, Corrective Action, Preventive Action)

    Upon establishing the root causes, a robust CAPA strategy was developed:

    1. Correction: Immediate retraining of the operators on proper techniques and protocols to rectify the current discrepancies in performance.
    2. Corrective Action: Re-evaluation of the OOS results with a revised methodology. This involved recalibrating all measuring equipment and procedures.
    3. Preventive Action: Development of enhanced training programs, supplemented by periodic assessments and audits of operations to mitigate recurrence.

    Control Strategy & Monitoring (SPC/Trending, Sampling, Alarms, Verification)

    Strengthening the control strategy is vital to ensuring continued compliance and mitigating further risks:

    • Statistical Process Control (SPC): Implementation of SPC tools to monitor critical quality attributes in real time.
    • Trending Analysis: Establishing control charts to detect deviations before they lead to OOS results.
    • Alarms and Alerts: Setting up alarm systems on sensitive equipment to inform users of out-of-band conditions immediately.
    • Verification Steps: Implementation of periodic reviews of sampling methods and batch documentation audits to ensure fidelity.

    Validation / Re-qualification / Change Control Impact (When Needed)

    Depending on the nature of the changes executed as part of the CAPA strategy, specific validation and change control measures may be necessary:

    • Validation of Processes: Any revised methods or equipment should undergo stringent validation protocols to ensure compliance and performance alignment.
    • Re-qualification of Equipment: Post-repair or recalibration, a re-qualification of any affected equipment should be performed to validate functionality.
    • Change Control Procedures: Any significant alterations to production protocols must be documented through proper change control, evaluated, and approved by management prior to execution.

    Inspection Readiness: What Evidence to Show

    Maintaining an inspection-ready environment necessitates systematic documentation and evidence collection:

    Related Reads

    • Records and Logs: Ensure all batch records reflect real-time data, including production logs, testing documentation, and any deviations encountered.
    • Training Documentation: Comprehensive records of staff training and any refreshers provided post-incident.
    • CAPA Documentation: A complete and systematically maintained CAPA log demonstrating the identification, analysis, and resolution processes.
    • Audit Trails: Maintain thorough audit trails for all equipment recalibrations, SOP adjustments, and quality testing.

    FAQs

    What should be the first step after detecting an issue during a site transfer?

    The immediate step is to quarantine any affected batches and materials, followed by convening your cross-functional teams to assess the situation.

    How can I ensure effective CAPA implementation?

    Develop a structured CAPA strategy incorporating corrections, corrective actions, and preventive measures, and ensure comprehensive training for employees.

    When should I consider re-validation after a site transfer?

    A re-validation is necessary when there are significant alterations to process, equipment, or methods to guarantee ongoing compliance and performance.

    What records are necessary to demonstrate compliance during an inspection?

    Maintain records of batch production, testing, training, CAPA documentation, and audit trails of any equipment and processes.

    How often should we conduct training on SOPs?

    Regular training sessions should take place, ideally before each transfer or whenever changes occur in practices, with periodic refreshers for all personnel.

    How can I mitigate risks during the site-to-site transfer?

    Conduct thorough facility fit assessments, engage in comprehensive training, and ensure robust communication among teams involved in the transfer.

    What is the significance of SPC in a pharmaceutical setting?

    SPC helps monitor critical quality attributes statistically, enabling early detection of trends that could indicate a deviation before it affects product quality.

    Should equipment be validated prior to a site transfer?

    Yes, all equipment should be validated and calibrated prior to use at the new site to ensure it meets operational specifications and critical quality requirements.

    What role does documentation play in inspection readiness?

    Documentation serves as evidence of compliance, capturing all vital processes and changes to ensure transparency for regulatory scrutiny during inspections.

    How important is cross-functional collaboration during site transfers?

    Extremely important, as it fosters diverse perspectives and expertise, facilitating effective problem-solving and decision-making throughout the transfer.

    What actions should be prioritized if OOS results are found during transfer?

    Immediately quarantine affected batches, assess the causes, conduct an investigation, and then implement necessary corrections or adjustments.

    How can organizations ensure ongoing site readiness?

    Regular audits, continuous training, and timely updates to SOPs based on current regulations and operational practice can enhance site readiness.

    If you find our Articles useful
    Add us as preferred source on Google
    Pharma Tip:  Common Site-to-Site Transfer Failures and How to Prevent Them
    If you find our Articles useful
    Add us as preferred source on Google